UNSPSC 85815625: Introduction of high-dose interleukin-2 into central vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of high-dose interleukin-2 into central vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E04002

UNSPSC 85815625 Introduction of high-dose interleukin-2 into central vein, open approach is a Commodity code that exhibits minimal alignment with recent state and local procurement activity; the solicitations tagged under this clinical procedure code do not reflect the code's nominal scope. Instead, the opportunities in the dataset span telehealth platforms, nursing home operations, occupational health services, EMS billing, employee wellness programs, and behavioral health treatment—none of which match the specific medical procedure the code describes. The code shows little relevant recent activity, and the mismatch between the code label and the actual work being procured suggests either a systematic tagging error or that this code sees negligible use in state and local contracting.

The recent opportunities posted under this code span issuing bodies ranging from health plans and state health authorities to county and city departments, reflecting a fragmented buyer base across California, Georgia, and Nevada with some additional activity in Colorado, Texas, Florida, and New York. Inland Empire Health Plan issued an RFI on October 16, 2026 (due October 31) for 24/7/365 virtual urgent care services delivered through California board-certified physicians; DeKalb County, Georgia posted an RFP for generic medical services with no scope detail (due November 12, 2026); and the Nevada Health Authority released two substantial RFPs—one for Program of All Inclusive Care for the Elderly (PACE) operations across Clark, Washoe, and rural Nevada counties (due December 10, 2026) with fixed monthly capitation ranging from $4,532.24 to $8,804.32 per participant and a contract term through December 31, 2032, and another for a Rural Value Acceleration Network vendor to facilitate statewide value-based care initiatives (due November 30, 2026). The dataset also includes opportunities for cancer registry services, retinal screening devices, EMT staffing, employee health clinics, and numerous other health service categories that do not correspond to the code's procedural definition. The geographic spread reflects California, Georgia, Nevada, Colorado, Texas, and several other states, but the absence of opportunities that actually match the interleukin-2 infusion procedure indicates this code is not a productive vehicle for business development in state and local procurement right now.